Here are relevant reports on : pregnancy-test-kits-market
-
Cable Testing and Certification Market by Voltage (Low Voltage, Medium Voltage and High Voltage), Test (Routine Test, Sample Test and Type Test), End-User (Cable Manufacturers and Utility Providers), and Region - Global Forecast to 2023
The market for cable testing and certification is projected to grow from USD 11.3 billion in 2018 to USD 14.7 billion by 2023, at a compound annual growth rate (CAGR) of 5.4% during the forecast period. Cable testing and certification are widely used to verify the cable’s safety and efficiency. The growth of the cable testing and certification market is, therefore, directly associated with the growing demand for cables in the electrical & electronics, transportation, and energy generation & distribution applications.DEKRA (Germany), Underwriters Laboratories (US), British Approvals Service for Cables (UK), SGS (Switzerland), BRE Global (UK), TÜV Rheinland (Germany), Bureau Veritas (France), Intertek (UK), TÜV NORD GROUP (Germany), North Central Electric (US), RN Electronics (UK), TÜV SÜD (Germany), Eland Cables (UK), and Industrial Tests (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
-
Lateral Flow Assays Market by Product (Kits, Readers), Application (HIV, HPV, TB, Cardiac Marker, Pregnancy, Hepatitis, Food Safety), Sample (Blood, Urine, Saliva), Technique (Sandwich, Competitive), End User (Hospitals), Region - Global Forecast to 2031
The global lateral flow assays market is projected to reach USD 13.52 billion by 2031, growing at a CAGR of 8.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Molecular Biology Enzymes Market by Product (Kits, Reagents, Enzyme), Application (PCR, Sequencing, Epigenetic, Synthetic Biology), End user (Research Institutes, Pharma & Biotech Company, Hospitals) and Region - Global Forecast to 2026
The global molecular biology enzymes market in terms of revenue was estimated to be worth $15.3 billion in 2021 and is poised to reach $29.7 billion by 2026, growing at a CAGR of 14.2% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: May 2021
- Price: $ 4950
- TOC Available:
-
Wine Testing Market by Type (Chemical, Microbial, Sensory Analysis, Contaminant), Technology (Manual/Wet Chemistry, Spectroscopy, Chromatography, Rapid Detection Kits, AI & Machine Learning), End-User, and Region - Global Forecast to 2030
The wine testing market is projected to expand from USD XX million in 2025 to USD XX million by 2030, at a CAGR of XX% during the forecast period. The report profiles key players such as ETS Laboratories (US), Enartis USA (US), Brewing and Distilling Analytical Services - BDAS (US), WineChek (US), bioMérieux (France), Agilent (US), Hanna Instruments (US), LabLynx (US), SGS (Switzerland), Eurofins (Luxembourg), TÜV SÜD (Germany), ALS Limited (Australia), Bureau Veritas S.A. France, Intertek Group plc (UK), Romer Labs Division Holding GmbH (Austria).
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Specimen Validity Testing Market by Product (Reagent, Controls, Assay Kits, Disposables), Type (Laboratory, POC Testing), End User (Workplace, Drug Screening, Pain Management, Drug Rehabilitation Centers) - Global Forecast to 2023
The global specimen validity testing market is projected to reach USD 1.49 Billion by 2023 from USD 1.10 Billion in 2018, at a CAGR of 6.3%. The growth of the market is primarily driven by the growth in drug screening market and increase in workplace drug testing. While the specimen validity testing market represents significant growth opportunities, market growth may be hindered due to the emergence of alternative drug screening tests. The specimen validity testing market is marked by the presence of several big and small players. Prominent players offering specimen validity testing products include Thermo Fisher Scientific (US), Sciteck, Inc. (US), American Bio Medica Corporation (ABMC), Alere [now a part of Abbott (US)], Express Diagnostics Int'l, Inc. (US), and Premier Biotech, Inc. (US). While, Laboratory Corporation of America Holdings (LabCorp) (US), Quest Diagnostics (US), Alere Toxicology (Alere) (US), ACM Global Laboratories (US), Clinical Reference Laboratory (CRL) (US), SureHire (Canada), and CannAmm (Canada) are some of the leading service providers.
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), Enduser (Hospital, Diagnostic & Research Labs) - Global Forecast to 2025
The global albumin & creatinine tests market growth is primed to transition from $987 million in 2020 to $2,103 million by 2025, showcasing a strong CAGR of 16.3%. The growth of this market is driven by the growing prevalence of kidney disorders and diseases, the rising adoption of POC diagnostics, and the increasing prevalence of chronic conditions.
- Published: January 2021
- Price: $ 4950
- TOC Available:
-
Companion Diagnostics Market by Product (Assays, Kits, & Reagents, Instruments, Software), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Lung, Colorectal Cancer, CVD, Infectious), Drug Class (MAB, Cell & Gene Therapy) - Global Forecast to 2031
The global companion diagnostics market is projected to reach USD 11.57 billion by 2031, growing at a CAGR of 12.9% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Nucleic Acid Labeling Market by Product (Reagents & Kits, Services), Applications, Labeling Techniques (PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription, End Labeling), by Region - Global Forecast to 2020
The global nucleic acid labeling market is expected to USD 1,925.7 Million by 2020 from USD 1271.8 Million in 2015, at a CAGR of 8.65% between 2015 and 2020. Nucleic acid can be labeled using several different methods including incorporation of fluorescent tags, biotin, and enzymes. The labeled nucleic acid can be used for a variety of applications, including DNA sequencing, PCR, FISH, microarrays, blotting, and in situ hybridization. This market report studies the potential of reagents & kits and services for various applications by using PCR, nick translation, random primer labeling techniques.
- Published: December 2015
- Price: $ 4950
- TOC Available:
-
Europe Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA, mRNA), Application (Diagnostics, Personalized Medicine), End User (CROs) - Forecast to 2030
The Europe nucleic acid isolation and purification market, valued at USD1.52 billion in 2024, stood at USD1.61 billion in 2025 and is projected to advance at a resilient CAGR of 8.4% from 2025 to 2030, culminating in a forecasted valuation of USD2.41 billion by the end of the period. The growth of the Europe nucleic acid isolation and purification market is strongly linked to the region’s high volume of molecular tests and the steady adoption of PCR- and NGS-based workflows.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Virology Specimen Collection Market by Product (Viral Transport Media, Swabs, Blood Collection Kits, Specimen Collection Tubes), Sample Type (Blood, Cervical, Nasal, Nasopharyngeal, Throat, Oral), Region - Global Forecast to 2026
The global Virology Specimen Collection Market boasts a total value of $5.6 billion in 2021 and is projected to register a growth rate of -0.6% to reach a value of $5.4 billion by 2026. The major players operating in this market are Becton, Dickinson and Company (US), Quidel Corporation (US), Thermo Fisher Scientific, Inc. (US), Trinity Biotech (Ireland), Titan Biotech, Ltd. (India), Diasorin SA (Italy), Vircell S.L. (Spain), Copan Italia S.p.A. (Italy), Puritan Medical Products, Co. (Guilford, ME) and Hardy Diagnostics (US).
- Published: December 2021
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
